Broadwood Partners, L.P.'s Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Feb 10, 2025
- Accession no.
- 0000919574-25-000922
- Filed
- Feb 10, 2025, 8:43 PM ET
- Trade date
- Feb 6, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $10.6M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadwood Partners, L.P.CIK 0001278386 | 10% Owner |
| Broadwood Capital IncCIK 0001278387 | 10% Owner |
| Bradsher Neal CCIK 0001278388 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 | Common Stock, no par value | PPurchaseAcquired | +660,207 | $2.05F3 | +$1,353,424.35 | 6,904,612 | Direct | |
| Feb 6, 2025 | Common Stock, no par value | PPurchaseAcquired | 0 | $0.00 | $0 | 6,904,612 | Indirect | |
| Feb 6, 2025 | Common Stock, no par value | PPurchaseAcquired | +4,505,488 | $2.05F4 | +$9,236,250.4 | 11,410,100 | Direct | |
| Feb 6, 2025 | Common Stock, no par value | PPurchaseAcquired | 0 | $0.00 | $0 | 11,410,100 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
On February 6, 2025, Broadwood Partners entered into a Securities Purchase Agreement with Oncocyte Corporation (the "Issuer") pursuant to which Broadwood Partners agreed to acquire 660,207 shares of the Issuer's Common Stock, no par value (the "Common Shares"), from the Issuer in a registered direct offering for a total purchase price of $1,353,424, or $2.05 per Common Share.
Referenced by the price of 1 transaction in Table I.
- F4
On February 6, 2025, Broadwood Partners entered into a Securities Purchase Agreement with the Issuer pursuant to which Broadwood Partners agreed to acquire 4,505,488 shares of Common Shares, from the Issuer in a private placement for a total purchase price of $9,236,250, or $2.05 per Common Share.
Referenced by the price of 1 transaction in Table I.